Transparency

What we already publish

Our mission, methodology, editorial standards, and how statistics are calculated are already public. See the Methodology and Research and Evidence pages.

Annual Transparency Report

Once active, the Annual Transparency Report is intended to cover the first reporting period forward: observations received; rejected or moderated submissions; withdrawals; corrections; scientific reviews; reviewer conflicts; funding sources; major methodology changes; and security or privacy events where appropriate. Governance activity, known limitations, unresolved problems, and active research collaborations are also intended to be covered. Historical statistics will not be invented to backfill periods before reporting begins.

Version 1 reporting will be manually compiled. Automated transparency reporting is deferred to a later version. No such automation exists today.

Funding

We do not accept funding from peptide manufacturers, distributors, or sellers. There is currently no funding to disclose. Once real funding exists, disclosures will identify appropriate categories such as donations, grants, sponsorships, merchandise, and institutional support, and will link those disclosures to the scientific-independence rules. Funding sources will be disclosed publicly through the Annual Transparency Report.

What we do not publicly disclose

Contributor identities, authentication information, fraud-detection methods, moderation security signals, withdrawal tokens, security procedures, privileged legal communications, and confidential personnel matters are not publicly disclosed.

Incidents

Significant methodology errors, material corrections, privacy or security incidents, governance failures, and funding issues are disclosed publicly without exposing information that would worsen the underlying problem or compromise contributor privacy.

Questions

Reasonable public questions can be submitted through the Contact page.